As can be seen, the canonical NF-κB pathway is essential to tumor development as well as angiogenesis in NPC, suggesting that the NF-κB pathway including its upstream modulators and downstream effectors, is a potential therapeutic target for NPC. The gene discussed is NFKB1; the disease is neoplasm.